LifeStance Health Group

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

LifeStance Health Group reports strong Q4 performance and outlines growth strategies for 2023

LifeStance Health Group's Q4 2022 performance reflects financial stability and operational strength, meeting expectations.
The company's strategic focus on long-term profitability, clinician growth, and value-based care positions it for future success.
Challenges include consolidation efforts, payer contracting complexities, and transitioning to an integrated care model.
Opportunities for growth lie in collaboration with physical care providers, value-based care models, and data-driven approaches.

LifeStance Health Group exceeds Q1 expectations, eyes sustainable growth

LifeStance Health Group's Q1 2023 performance showcased strong financial results and operational advancements, driven by clinician growth and strategic initiatives.
While facing challenges such as clinician recruitment and margin progression, the company's focus on retention and value-based care initiatives bodes well for future growth.
With opportunities in clinician expansion, operational enhancements, and market adaptation, LifeStance Health Group is poised to capitalize on emerging trends and drive sustainable success.

LifeStance Health Group excels in Q2, eyes growth opportunities

LifeStance Health Group's Q2 2023 earnings call highlighted strong financial performance, operational improvements, and a strategic focus on enhancing patient care and value-based care arrangements. The company is navigating challenges in streamlining operations and adapting to regulatory changes while capitalizing on opportunities to drive growth and operational efficiencies.

LifeStance Health Group exceeds Q3 expectations, focuses on growth

LifeStance Health Group's Q3 2023 performance reflects strong revenue growth, operational improvements, and a focus on patient and clinician satisfaction.
While facing challenges such as negative free cash flow and ongoing legal actions, the company is poised for growth through revenue guidance increases and strategic investments.
Opportunities for revenue growth, clinician expansion, and enhanced patient experiences align with the company's commitment to quality care and financial performance.
CEO Ken Burdick's emphasis on exceeding expectations, raising guidance, and navigating legal challenges underscores the company's resilience and strategic direction.

LifeStance Health Group beats 2023 metrics, focuses on growth optimization

LifeStance Health Group's strong financial performance in 2023 reflects a focus on profitability, clinician growth, and patient experience, with plans for continued optimization.
Strategic investments in technology and operational processes position the company for future success, while challenges in moderating growth and improving funnel efficiency require attention.
Opportunities lie in enhancing patient acquisition and retention, clinician productivity, and operational efficiency, leveraging the company's early growth stage for scalability.
Management's commitment to a purpose-driven culture and operational excellence, supported by a dedicated team, underpins LifeStance Health Group's path to sustained success.

LifeStance Health Group excels in Q1 2024, eyes growth opportunities

LifeStance Health Group's Q1 2024 Earnings Call showcased robust financial performance, strategic resilience, and a focus on growth. While facing leadership transitions and short-term challenges, the company is poised for positive cash flow and continued improvements in revenue and margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LOS ANGELES, CA / ACCESSWIRE / July 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Is Examining LifeStance Health Group Inc And Encourages Impacted Investors To Initiate Dialogue

LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

All You Need to Know About LifeStance Health (LFST) Rating Upgrade to Strong Buy

LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Is Examining LifeStance Health Group Inc And Urges Impacted Investors To Begin Dialogue

LOS ANGELES, CA / ACCESSWIRE / July 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

LifeStance Health Group Inc Is Under The Schall Law Firm's Scrutiny And Affected Investors Are Encouraged To Initiate Conversations

SCOTTSDALE, Ariz., July 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2024 earnings release before the market opens on Thursday, August 8, 2024.

LifeStance to Host Second Quarter 2024 Earnings Conference Call on August 8, 2024

LOS ANGELES, CA / ACCESSWIRE / July 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

LifeStance Health Group Inc Is Under Examination By The Schall Law Firm, Affected Investors Are Encouraged To Initiate Conversations

LOS ANGELES, CA / ACCESSWIRE / July 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Urges Impacted Investors To Start Dialogue, LifeStance Health Group Inc Is Under Scrutiny

LOS ANGELES, CA / ACCESSWIRE / July 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

LifeStance Health Group Inc Under Investigation By The Schall Law Firm Encouraging Affected Investors To Initiate Conversation

LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

LifeStance Health Group Inc Under Investigation By The Schall Law Firm Encourages Affected Investors To Start Conversation

LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Is Investigating LifeStance Health Group Inc And Invites Impacted Investors To Begin Dialogue

The average of price targets set by Wall Street analysts indicates a potential upside of 57.4% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts See a 57.38% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?

LOS ANGELES, CA / ACCESSWIRE / July 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Begins Inquiry Into LifeStance Health Group Inc And Urges Impacted Investors To Start Dialogue

LOS ANGELES, CA / ACCESSWIRE / July 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Starts Investigation Into LifeStance Health Group Inc And Encourages Affected Investors To Initiate Conversation

LOS ANGELES, CA / ACCESSWIRE / July 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Initiates Examination Into LifeStance Health Group Inc And Urges Impacted Investors To Start Communication

LOS ANGELES, CA / ACCESSWIRE / July 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Initiates Scrutiny Of Claims Against LifeStance Health Group Inc And Promotes Investors With Losses To Start Communication

LOS ANGELES, CA / ACCESSWIRE / July 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Inquiry Into LifeStance Health Group Inc Is Launched By The Schall Law Firm And It Encourages Affected Investors To Commence Dialogue

LOS ANGELES, CA / ACCESSWIRE / July 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Begins Examination Into Allegations Against LifeStance Health Group Inc And Urges Impacted Investors To Initiate Interaction

LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Begins Inquiry Into Allegations Against LifeStance Health Group Inc And Urges Affected Investors To Initiate Communication

LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Probe Into Claims Against LifeStance Health Group Inc Initiated By The Schall Law Firm And Impacted Investors Are Encouraged To Start Contact

LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Begins Investigation Into Allegations Against LifeStance Health Group Inc And Encourages Affected Investors To Establish Communication

LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Initiates Probe Into Claims Against LifeStance Health Group Inc And Urges Impacted Investors To Initiate Contact

LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Begins Investigation Into Allegations Against LifeStance Health Group Inc And Urges Affected Investors To Initiate Contact

LOS ANGELES, CA / ACCESSWIRE / June 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Initiates Probe Into Claims Against LifeStance Health Group Inc And Encourages Impacted Investors To Establish Communication

LOS ANGELES, CA / ACCESSWIRE / June 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Starts Investigation Into Allegations Against LifeStance Health Group Inc And Recommends Affected Investors To Reach Out

LOS ANGELES, CA / ACCESSWIRE / June 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

News for LifeStance Health Group Stock (LFST)